/Companies

Brenig Therapeutics, Inc.

Dover, US · Founded 2021 · Delaware corporation · 1 known investors

Find your way into Brenig Therapeutics, Inc.

Sign up to see every warm intro you have to Brenig Therapeutics, Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Brenig Therapeutics, Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

ID
Iain DukesNamed on SEC filing
NS
Nikolay SavchukNamed on SEC filing

Board

KG
Keno GutierrezBoard director
EM
Edward MathersBoard directorGeneral Partner at NEA Secondary
MC
Michele CuculluBoard director

Investors · 1

New Enterprise Associates (NEA)reportedMenlo Park · $200K – $40M

How we know: a partner's Signal profile · funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$30M disclosed across 1 round · 2024

▶$30MraisedJul 2024 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keno GutierrezDirector
  • Iain DukesExecutive Officer, Director
  • Edward MathersDirector
  • Nikolay SavchukExecutive Officer, Director
  • Michele CuculluDirector
Offering amount
$65M
Amount sold
$30M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Brenig Therapeutics, Inc.'s investors?
Brenig Therapeutics, Inc.'s investors include New Enterprise Associates (NEA).
How much funding has Brenig Therapeutics, Inc. raised?
Brenig Therapeutics, Inc. has disclosed $30M raised across 1 round.
Where is Brenig Therapeutics, Inc. headquartered?
Brenig Therapeutics, Inc. is headquartered in Dover, US.